COSMO Pharmaceuticals SA (0RGI) — Financial Flexibility Index
COSMO Pharmaceuticals SA (0RGI) has a Financial Flexibility Index of 0.02x as of June 2025. Free cash flow of £3.52 Million (operating CF £900.00K minus capex £2.62 Million) represents 0% of total liabilities (£143.35 Million). Also explore 0RGI net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
COSMO Pharmaceuticals SA Financial Flexibility Index (2004–2024)
Historical Financial Flexibility Index trend for COSMO Pharmaceuticals SA across 21 annual periods. Check how strategically is COSMO Pharmaceuticals SA's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for COSMO Pharmaceuticals SA (2004–2024)
Year-by-year free cash flow to debt coverage for COSMO Pharmaceuticals SA. For the full company profile including market capitalisation, see 0RGI market cap overview.
| Year | Flexibility Index | Free Cash Flow (GBP) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.19x | £168.06 Million | £162.41 Million | £141.68 Million | ▲ +446.8% |
| 2023 | 0.22x | £27.10 Million | £22.71 Million | £124.94 Million | ▲ +71.7% |
| 2022 | 0.13x | £37.37 Million | £32.89 Million | £295.80 Million | ▲ +75.2% |
| 2021 | 0.07x | £21.11 Million | £12.61 Million | £292.88 Million | ▼ -32.9% |
| 2020 | 0.11x | £21.07 Million | £12.98 Million | £196.04 Million | ▲ +1441.2% |
| 2019 | -0.01x | £-1.53 Million | £-18.85 Million | £191.43 Million | ▼ -194.5% |
| 2018 | 0.00x | £-492.00K | £-10.16 Million | £180.83 Million | ▼ -100.6% |
| 2017 | 0.43x | £12.03 Million | £-10.01 Million | £27.86 Million | ▼ -73.1% |
| 2016 | 1.61x | £44.84 Million | £26.41 Million | £27.92 Million | ▲ +250.1% |
| 2015 | -1.07x | £-36.69 Million | £-39.23 Million | £34.30 Million | ▼ -213.8% |
| 2014 | 0.94x | £68.96 Million | £66.45 Million | £73.33 Million | ▲ +98.2% |
| 2013 | 0.47x | £10.84 Million | £8.11 Million | £22.85 Million | ▼ -50.4% |
| 2012 | 0.96x | £26.04 Million | £23.00 Million | £27.24 Million | ▼ -4.8% |
| 2011 | 1.00x | £14.66 Million | £11.29 Million | £14.60 Million | ▲ +120.9% |
| 2010 | 0.45x | £15.21 Million | £7.79 Million | £33.46 Million | ▼ -49.9% |
| 2009 | 0.91x | £10.60 Million | £3.88 Million | £11.67 Million | ▲ +285.1% |
| 2008 | -0.49x | £-7.13 Million | £-12.52 Million | £14.53 Million | ▼ -306.2% |
| 2007 | -0.12x | £-1.46 Million | £-2.52 Million | £12.08 Million | ▼ -115.6% |
| 2006 | 0.78x | £14.18 Million | £6.08 Million | £18.27 Million | ▲ +262.9% |
| 2005 | 0.21x | £5.90 Million | £1.70 Million | £27.58 Million | ▲ +92.6% |
| 2004 | 0.11x | £2.70 Million | £261.00K | £24.34 Million | — |